abstract |
The present invention relates to novel 4-piperazinylpyrimidine compounds. The compounds possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of the dopamine D 3 receptor. The 4-piperzinylpyrimidine compounds have the general formula I n n n n n n n n n n wherein Ar, X, A, R 1 and R 1a are as defined in the claims. |